These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9152487)

  • 1. Asymptomatic microembolism in patients with long-term ventricular assist support.
    Moazami N; Roberts K; Argenziano M; Catanese K; Mohr JP; Rose EA; Oz MC
    ASAIO J; 1997; 43(3):177-80. PubMed ID: 9152487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices.
    Slater JP; Rose EA; Levin HR; Frazier OH; Roberts JK; Weinberg AD; Oz MC
    Ann Thorac Surg; 1996 Nov; 62(5):1321-7; discussion 1328. PubMed ID: 8893563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device.
    Thoennissen NH; Schneider M; Allroggen A; Ritter M; Dittrich R; Schmid C; Scheld HH; Ringelstein EB; Nabavi DG
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1159-66. PubMed ID: 16214534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices. A prospective study.
    Nabavi DG; Georgiadis D; Mumme T; Schmid C; Mackay TG; Scheld HH; Ringelstein EB
    Stroke; 1996 May; 27(5):891-6. PubMed ID: 8623109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of inflammation and pump dynamic on cerebral microembolization in patients with Continuous-Flow DeBakey LVAD.
    Thoennissen NH; Allroggen A; Ritter M; Dittrich R; Schmid C; Schmid HH; Ringelstein EB; Nabavi DG
    ASAIO J; 2006; 52(3):243-7. PubMed ID: 16760711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device.
    Schmid C; Weyand M; Nabavi DG; Hammel D; Deng MC; Ringelstein EB; Scheld HH
    Ann Thorac Surg; 1998 Jun; 65(6):1703-10. PubMed ID: 9647085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doppler-sonographic evidence of cerebral microembolism originating from a biventricular assist device.
    Buhre W; Buhre K; Aleksic I; Zenker D; Sonntag H; Weyland A
    Thorac Cardiovasc Surg; 2000 Oct; 48(5):300-2. PubMed ID: 11100764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
    Slaughter MS; Sobieski MA; Gallagher C; Dia M; Silver MA
    Tex Heart Inst J; 2008; 35(3):245-9. PubMed ID: 18941649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HeartMate left ventricular assist device for long-term circulatory support.
    Hsu RB; Chu SH; Chien CY; Ko WJ; Chou NK; Chen YS; Wang SS
    J Formos Med Assoc; 2000 Apr; 99(4):336-40. PubMed ID: 10870319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism.
    Rose EA; Levin HR; Oz MC; Frazier OH; Macmanus Q; Burton NA; Lefrak EA
    Circulation; 1994 Nov; 90(5 Pt 2):II87-91. PubMed ID: 7955291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High intensity transient signals (HITS) in patients with carotid artery disease.
    Ries S; Schminke U; Daffertshofer M; Hennerici M
    Eur J Med Res; 1996 Apr; 1(7):328-30. PubMed ID: 9364033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microemboli during coronary artery bypass grafting. Genesis and effect on outcome.
    Clark RE; Brillman J; Davis DA; Lovell MR; Price TR; Magovern GJ
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):249-57; discussion 257-8. PubMed ID: 7853878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients.
    Nabavi DG; Stockmann J; Schmid C; Schneider M; Hammel D; Scheld HH; Ringelstein EB
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):160-7. PubMed ID: 12878951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial high-intensity transient signals after homograft or mechanical aortic valve replacement.
    Lievense AM; Bakker SL; Dippel DW; Taams MA; Koudstaal PJ; Bogers AJ
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):613-7. PubMed ID: 9833721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency analysis of high-intensity transient signals of transcranial Doppler ultrasound in patients supported with a left ventricular assist device.
    Sato K; Hanzawa K; Okamoto T; Kyo S; Hayashi J
    J Artif Organs; 2008; 11(4):201-3. PubMed ID: 19184284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.